Alcon to Acquire Aerie Pharmaceuticals for US$770 M
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 8 (Table of Contents)
Published: 26 Aug-2022
DOI: 10.3833/pdr.v2022.i8.2718 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its presence in the ophthalmic pharmaceutical eye drop space, Alcon has entered into a definitive merger agreement with Aerie Pharmaceuticals through which Alcon will acquire Aerie for US$15...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS